Company Number: 13970359

Analysis Date: 2025-07-29 19:35 UTC

Financial Health Assessment of PEAL ATHENA LTD as at 31 December 2023

---

1. Financial Health Score: B-

Explanation:
The company demonstrates a solid equity base and a strong working capital position ("healthy cash flow cushion"), but there are signs of "internal strain" reflected in the steep drop of fixed asset investments and a significant negative profit and loss reserve. These symptoms suggest financial stress or a restructuring phase, warranting caution.

---

2. Key Vital Signs

Metric	2023 Value	Interpretation
Current Assets	£2,152,736	Adequate liquidity; primarily composed of debtors (accounts receivable)
Cash at Bank	£22,528	Very low cash balance, potential liquidity risk for immediate needs
Debtors	£2,130,208	High debtor balance; risk of cash flow delay if collection is slow
Current Liabilities	£59,800	Low short-term obligations; manageable relative to assets
Net Current Assets	£2,092,936	Strong working capital; positive sign of short-term financial health
Fixed Asset Investments	£351,900	Sharp decrease from previous year (£6.4M in 2022); possible asset sale or impairment
Shareholders’ Funds (Equity)	£2,444,836	Positive net worth, but down from £7.1M prior year
Profit & Loss Reserve	(£5,871,247)	Large accumulated losses; "symptom of distress" on retained earnings
Called-up Share Capital	£100	Nominal; typical for private limited companies
Related Party Debtors	£2,115,747	High related party balances; potential risk if these are not collectible

---

3. Diagnosis

PEAL ATHENA LTD shows mixed financial health signs. The company boasts a strong working capital position with current assets substantially exceeding current liabilities, which is like a "healthy pulse" indicating the ability to meet short-term obligations comfortably. However, the very low cash reserves suggest a "low blood pressure" situation where immediate liquidity might be tight, possibly due to the high concentration in debtors.

The most concerning "symptom" is the dramatic decrease in fixed asset investments—from £6.4 million in 2022 to just £351,900 in 2023—indicating either significant disposals or write-downs of investments. This is coupled with a sharply negative profit and loss reserve of nearly £5.9 million, showing accumulated losses or impairments that have eroded retained earnings. Such a deficit is a "chronic condition" that could undermine long-term financial stability if not addressed.

The equity base has shrunk from £7.1 million to £2.4 million, reflecting these losses and asset reductions. The company is still solvent with positive net assets but the downward trend suggests a "weakening immune system" against financial stress.

Additionally, a large portion of current assets are debtors, including significant amounts owed by related parties. This concentration risk could delay cash inflows and strain the company’s liquidity if collections slow down.

---

4. Recommendations

• Improve Cash Reserves: Actively manage cash flow and expedite debtor collections to build a healthier cash buffer and reduce "low blood pressure" risk.

• Evaluate Debtor Quality: Conduct a thorough review of outstanding debtors, especially related party receivables, to assess collectability and consider provisions for bad debts.

• Asset Strategy Review: Clarify the reasons behind the large reduction in fixed asset investments. If disposals were for restructuring, ensure proceeds strengthen liquidity or reduce debts. If impairments, investigate underlying causes and management responses.

• Address Profit & Loss Deficit: Develop a turnaround plan to return the business to profitability, focusing on cost control and revenue growth. The "chronic condition" of accumulated losses needs active management to restore retained earnings.

• Strengthen Financial Monitoring: Implement tighter financial controls and regular liquidity forecasting to detect early warning signs and react proactively.

• Related Party Transactions: Ensure transparency and arm’s length terms in related party dealings to prevent potential conflicts of interest or financial misstatements.

---